Healthpeak Properties (NYSE:DOC) Given New $21.00 Price Target at Cantor Fitzgerald

Healthpeak Properties (NYSE:DOC) had its target price reduced by Cantor Fitzgerald from $23.00 to $21.00 in a research note released on Wednesday,Benzinga reports. Cantor Fitzgerald currently has a neutral rating on the real estate investment trust’s stock.

Several other research analysts also recently commented on DOC. Barclays reduced their target price on Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 13th. Robert W. Baird raised their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Thursday, August 13th. Jefferies Financial Group initiated coverage on Healthpeak Properties in a report on Tuesday, September 15th. They set a “hold” rating and a $21.00 price target for the company. Wells Fargo & Company cut their price objective on Healthpeak Properties from $22.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Finally, UBS Group reduced their price objective on Healthpeak Properties from $21.50 to $20.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and an average target price of $21.47.

Healthpeak Properties Price Performance

NYSE:DOC opened at $20.19 on Wednesday. The firm has a market cap of $13.92 billion, a PE ratio of 37.40, a price-to-earnings-growth ratio of 2.41 and a beta of 1.01. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a quick ratio of 3.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.87. The company’s 50-day moving average price is $19.79 and its two-hundred day moving average price is $19.17.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41). The firm had revenue of $820.89 million for the quarter, compared to the consensus estimate of $739.18 million. Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. Healthpeak Properties’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.46 earnings per share. On average, equities analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.0%. Healthpeak Properties’s payout ratio is currently 225.93%.

Hedge Funds Weigh In On Healthpeak Properties

A number of large investors have recently modified their holdings of the stock. Pension & Wealth Management Advisors Inc. acquired a new stake in Healthpeak Properties in the third quarter worth about $27,000. Clearstead Trust LLC raised its holdings in Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 543 shares during the last quarter. Security National Bank of SO Dak acquired a new position in Healthpeak Properties during the 2nd quarter valued at about $32,000. Latitude Advisors LLC acquired a new position in Healthpeak Properties during the 3rd quarter valued at about $34,000. Finally, Markowski Investments acquired a new position in Healthpeak Properties during the 2nd quarter valued at about $38,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Healthpeak Properties

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Healthpeak raised its 2026 adjusted FFO guidance to $1.76–$1.78 per share, broadly in line with the $1.77 consensus. Management pointed to outpatient leasing and senior-housing growth, while Q3 revenue rose 16.3% year over year. Zacks article
• Positive Sentiment: Management described broad operating momentum and expects to lease up recently acquired lab properties over two to three years. A potential recovery in life-science real estate is also cited by analysts as a possible longer-term catalyst. Healthpeak guidance and lab lease-up
• Neutral Sentiment: Q3 results were mixed: adjusted FFO declined year over year, while revenue increased. Revenue also came in below one reported FactSet estimate, though it exceeded other estimates cited in coverage. Q3 results
• Negative Sentiment: Refinancing risk remains a concern, and Cantor Fitzgerald cut its price target from $23 to $21 while maintaining a neutral rating. The target reduction may limit enthusiasm despite the improved guidance. Refinancing risk coverage

Healthpeak Properties Company Profile

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.